References
- Abboud, M.M., Al Awaida, W., Alkhateeb, H.H., and Abu-Ayyad, A.N. (2019). Antitumor action of amygdalin on human breast cancer cells by selective sensitization to oxidative stress. Nutr. Cancer 71, 483-490. https://doi.org/10.1080/01635581.2018.1508731
- Ahn, S.M., Goode, R.J., and Simpson, R.J. (2008). Stem cell markers: insights from membrane proteomics? Proteomics 8, 4946-4957. https://doi.org/10.1002/pmic.200800312
- Bailey, P.C., Lee, R.M., Vitolo, M.I., Pratt, S.J.P., Ory, E., Chakrabarti, K., Lee, C.J., Thompson, K.N., and Martin, S.S. (2018). Single-cell tracking of breast cancer cells enables prediction of sphere formation from early cell divisions. iScience 8, 29-39. https://doi.org/10.1016/j.isci.2018.08.015
- Balk-Moller, E., Kim, J., Hopkinson, B., Timmermans-Wielenga, V., Petersen, O.W., and Villadsen, R. (2014). A marker of endocrine receptor-positive cells, CEACAM6, is shared by two major classes of breast cancer: luminal and HER2-enriched. Am. J. Pathol. 184, 1198-1208. https://doi.org/10.1016/j.ajpath.2013.12.013
- Baumann, M., Krause, M., and Hill, R. (2008). Exploring the role of cancer stem cells in radioresistance. Nat. Rev. Cancer 8, 545-554. https://doi.org/10.1038/nrc2419
- Blumenthal, R.D., Hansen, H.J., and Goldenberg, D.M. (2005). Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Cancer Res. 65, 8809-8817. https://doi.org/10.1158/0008-5472.CAN-05-0420
- Blumenthal, R.D., Leon, E., Hansen, H.J., and Goldenberg, D.M. (2007). Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. BMC Cancer 7, 2. https://doi.org/10.1186/1471-2407-7-2
- Britzen-Laurent, N., Lipnik, K., Ocker, M., Naschberger, E., Schellerer, V.S., Croner, R.S., Vieth, M., Waldner, M., Steinberg, P., Hohenadl, C., et al. (2013). GBP-1 acts as a tumor suppressor in colorectal cancer cells. Carcinogenesis 34, 153-162. https://doi.org/10.1093/carcin/bgs310
- Calvet, C.Y., Andre, F.M., and Mir, L.M. (2014). The culture of cancer cell lines as tumorspheres does not systematically result in cancer stem cell enrichment. PLoS One 9, e89644. https://doi.org/10.1371/journal.pone.0089644
- Cameron, S., de Long, L.M., Hazar-Rethinam, M., Topkas, E., Endo-Munoz, L., Cumming, A., Gannon, O., Guminski, A., and Saunders, N. (2012). Focal overexpression of CEACAM6 contributes to enhanced tumorigenesis in head and neck cancer via suppression of apoptosis. Mol. Cancer 11, 74. https://doi.org/10.1186/1476-4598-11-74
- Cao, Z., Livas, T., and Kyprianou, N. (2016). Anoikis and EMT: lethal 'liaisons' during cancer progression. Crit. Rev. Oncog. 21, 155-168. https://doi.org/10.1615/CritRevOncog.2016016955
- Chen, L.S., Wang, A.X., Dong, B., Pu, K.F., Yuan, L.H., and Zhu, Y.M. (2012). A new prospect in cancer therapy: targeting cancer stem cells to eradicate cancer. Chin. J. Cancer 31, 564-572. https://doi.org/10.5732/cjc.011.10444
- Colak, S. and Medema, J.P. (2014). Cancer stem cells--important players in tumor therapy resistance. FEBS J. 281, 4779-4791. https://doi.org/10.1111/febs.13023
- Crabtree, J.S. and Miele, L. (2018). Breast cancer stem cells. Biomedicines 6, 77. https://doi.org/10.3390/biomedicines6030077
- Deonarain, M.P., Kousparou, C.A., and Epenetos, A.A. (2009). Antibodies targeting cancer stem cells: a new paradigm in immunotherapy? MAbs 1, 12-25. https://doi.org/10.4161/mabs.1.1.7347
- Diaz-Fernandez, A., Miranda-Castro, R., de-Los-Santos-Alvarez, N., and Lobo-Castanon, M.J. (2018). Post-translational modifications in tumor biomarkers: the next challenge for aptamers? Anal. Bioanal. Chem. 410, 2059-2065. https://doi.org/10.1007/s00216-018-0861-9
- Dontu, G., Abdallah, W.M., Foley, J.M., Jackson, K.W., Clarke, M.F., Kawamura, M.J., and Wicha, M.S. (2003). In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270. https://doi.org/10.1101/gad.1061803
- Elias, D., Vever, H., Laenkholm, A.V., Gjerstorff, M.F., Yde, C.W., Lykkesfeldt, A.E., and Ditzel, H.J. (2015). Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy. Oncogene 34, 1919-1927. https://doi.org/10.1038/onc.2014.138
- Gemei, M., Mirabelli, P., Di Noto, R., Corbo, C., Iaccarino, A., Zamboli, A., Troncone, G., Galizia, G., Lieto, E., Del Vecchio, L., et al. (2013). CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo. Cancer 119, 729-738. https://doi.org/10.1002/cncr.27794
- Hamam, R., Hamam, D., Alsaleh, K.A., Kassem, M., Zaher, W., Alfayez, M., Aldahmash, A., and Alajez, N.M. (2017). Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. Cell Death Dis. 8, e3045. https://doi.org/10.1038/cddis.2017.440
- Henderson, T., Chen, M., Darrow, M.A., Li, C.S., Chiu, C.L., Monjazeb, A.M., Murphy, W.J., and Canter, R.J. (2018). Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas. J. Surg. Res. 223, 207-214. https://doi.org/10.1016/j.jss.2017.11.016
- Hertz, E., Cadona, F.C., Machado, A.K., Azzolin, V., Holmrich, S., Assmann, C., Ledur, P., Ribeiro, E.E., DE Souza Filho, O.C., Manica-Cattani, M.F., et al. (2015). Effect of Paullinia cupana on MCF-7 breast cancer cell response to chemotherapeutic drugs. Mol. Clin. Oncol. 3, 37-43. https://doi.org/10.3892/mco.2014.438
- Honeth, G., Bendahl, P.O., Ringner, M., Saal, L.H., Gruvberger-Saal, S.K., Lovgren, K., Grabau, D., Ferno, M., Borg, A., and Hegardt, C. (2008). The CD44+/CD24- phenotype is enriched in basal-like breast tumors. Breast Cancer Res. 10, R53. https://doi.org/10.1186/bcr2108
- Hong, K.P., Shin, M.H., Yoon, S., Ji, G.Y., Moon, Y.R., Lee, O.J., Choi, S.Y., Lee, Y.M., Koo, J.H., Lee, H.C., et al. (2015). Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity. Biomaterials 67, 32-41. https://doi.org/10.1016/j.biomaterials.2015.07.012
- Huang, R. and Rofstad, E.K. (2017). Cancer stem cells (CSCs), cervical CSCs and targeted therapies. Oncotarget 8, 35351-35367. https://doi.org/10.18632/oncotarget.10169
- Jaggupilli, A. and Elkord, E. (2012). Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity. Clin. Dev. Immunol. 2012, 708036.
- Johnson, B. and Mahadevan, D. (2015). Emerging role and targeting of carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) in human malignancies. Clin. Cancer Drugs 2, 100-111. https://doi.org/10.2174/2212697X02666150602215823
- Jung, H.J. (2017). Chemical proteomic approaches targeting cancer stem cells: a review of current literature. Cancer Genomics Proteomics 14, 315-327.
- Kim, M.H., Kim, M.H., Kim, K.S., Park, M.J., Jeong, J.H., Park, S.W., Ji, Y.H., Kim, K.I., Lee, T.S., Ryu, P.Y., et al. (2016). In vivo monitoring of CD44+ cancer stem-like cells by gamma-irradiation in breast cancer. Int. J. Oncol. 48, 2277-2286. https://doi.org/10.3892/ijo.2016.3493
- Kim, W.T. and Ryu, C.J. (2017). Cancer stem cell surface markers on normal stem cells. BMB Reports 50, 285. https://doi.org/10.5483/BMBRep.2017.50.6.039
- Kim, Y.J., Park, H.B., Kim, P.H., Park, J.S., and Kim, K.S. (2017). Enhanced anti-cancer efficacy in MCF-7 breast cancer cells by combined drugs of metformin and sodium salicylate. Biomed. Sci. Lett. 23, 290-294. https://doi.org/10.15616/BSL.2017.23.3.290
- Koch, U., Krause, M., and Baumann, M. (2010). Cancer stem cells at the crossroads of current cancer therapy failures--radiation oncology perspective. Semin. Cancer Biol. 20, 116-124. https://doi.org/10.1016/j.semcancer.2010.02.003
- Krishnamurthy, N. and Kurzrock, R. (2018). Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat. Rev. 62, 50-60. https://doi.org/10.1016/j.ctrv.2017.11.002
- Lee, E.C., Fitzgerald, M., Bannerman, B., Donelan, J., Bano, K., Terkelsen, J., Bradley, D.P., Subakan, O., Silva, M.D., Liu, R., et al. (2011). Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies. Clin. Cancer Res. 17, 7313-7323. https://doi.org/10.1158/1078-0432.CCR-11-0636
- Lee, H., Jang, Y., Park, S., Jang, H., Park, E.J., Kim, H.J., and Kim, H. (2018). Development and evaluation of a CEACAM6-targeting theranostic nanomedicine for photoacoustic-based diagnosis and chemotherapy of metastatic cancer. Theranostics 8, 4247-4261. https://doi.org/10.7150/thno.25131
- Lee, J.Y., Kim, D.G., Kim, B.G., Yang, W.S., Hong, J., Kang, T., Oh, Y.S., Kim, K.R., Han, B.W., Hwang, B.J., et al. (2014). Promiscuous methionyl-tRNA synthetase mediates adaptive mistranslation to protect cells against oxidative stress. J. Cell Sci. 127, 4234-4245. https://doi.org/10.1242/jcs.152470
- Leth-Larsen, R., Lund, R., Hansen, H.V., Laenkholm, A.V., Tarin, D., Jensen, O.N., and Ditzel, H.J. (2009). Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol. Cell. Proteomics 8, 1436-1449. https://doi.org/10.1074/mcp.M800061-MCP200
- Lin, S.E., Barrette, A.M., Chapin, C., Gonzales, L.W., Gonzalez, R.F., Dobbs, L.G., and Ballard, P.L. (2015). Expression of human carcinoembryonic antigen-related cell adhesion molecule 6 and alveolar progenitor cells in normal and injured lungs of transgenic mice. Physiol. Rep. 3, e12657. https://doi.org/10.14814/phy2.12657
- Lombardo, Y., de Giorgio, A., Coombes, C.R., Stebbing, J., and Castellano, L. (2015). Mammosphere formation assay from human breast cancer tissues and cell lines. J. Vis. Exp. 97, e52671.
- Luo, M., Clouthier, S.G., Deol, Y., Liu, S., Nagrath, S., Azizi, E., and Wicha, M.S. (2015). Breast cancer stem cells: current advances and clinical implications. Methods Mol. Biol. 1293, 1-49. https://doi.org/10.1007/978-1-4939-2519-3_1
- Maugeri-Sacca, M., Vigneri, P., and De Maria, R. (2011). Cancer stem cells and chemosensitivity. Clin. Cancer Res. 17, 4942-4947. https://doi.org/10.1158/1078-0432.CCR-10-2538
- Meacham, C.E. and Morrison, S.J. (2013). Tumour heterogeneity and cancer cell plasticity. Nature 501, 328-337. https://doi.org/10.1038/nature12624
- Morrison, B.J., Hastie, M.L., Grewal, Y.S., Bruce, Z.C., Schmidt, C., Reynolds, B.A., Gorman, J.J., and Lopez, J.A. (2012). Proteomic comparison of mcf-7 tumoursphere and monolayer cultures. PLoS One 7, e52692. https://doi.org/10.1371/journal.pone.0052692
- Nassar, D. and Blanpain, C. (2016). Cancer stem cells: basic concepts and therapeutic implications. Annu. Rev. Pathol. 11, 47-76. https://doi.org/10.1146/annurev-pathol-012615-044438
- Nie, S., McDermott, S.P., Deol, Y., Tan, Z., Wicha, M.S., and Lubman, D.M. (2015). A quantitative proteomics analysis of MCF7 breast cancer stem and progenitor cell populations. Proteomics 15, 3772-3783. https://doi.org/10.1002/pmic.201500002
- Nilendu, P., Kumar, A., Kumar, A., Pal, J.K., and Sharma, N.K. (2018). Breast cancer stem cells as last soldiers eluding therapeutic burn: a hard nut to crack. Int. J. Cancer 142, 7-17. https://doi.org/10.1002/ijc.30898
- Panczyszyn, A. and Wieczorek, M. (2012). [Role of CEACAM in neutrophil activation]. Postepy Hig. Med. Dosw. (Online) 66, 574-582. Polish. https://doi.org/10.5604/17322693.1008194
- Pecina, P., Nuskova, H., Karbanova, V., Kaplanova, V., Mracek, T., and Houstek, J. (2018). Role of the mitochondrial ATP synthase central stalk subunits gamma and delta in the activity and assembly of the mammalian enzyme. Biochim. Biophys. Acta Bioenerg. 1859, 374-381. https://doi.org/10.1016/j.bbabio.2018.02.007
- Pogozheva, I.D., Tristram-Nagle, S., Mosberg, H.I., and Lomize, A.L. (2013). Structural adaptations of proteins to different biological membranes. Biochim. Biophys. Acta 1828, 2592-2608. https://doi.org/10.1016/j.bbamem.2013.06.023
- Qiu, X., Guo, H., Yang, J., Ji, Y., Wu, C.S., and Chen, X. (2018). Downregulation of guanylate binding protein 1 causes mitochondrial dysfunction and cellular senescence in macrophages. Sci. Rep. 8, 1679. https://doi.org/10.1038/s41598-018-19828-7
- Quintero, M., Adamoski, D., Reis, L.M.D., Ascencao, C.F.R., Oliveira, K.R.S., Goncalves, K.A., Dias, M.M., Carazzolle, M.F., and Dias, S.M.G. (2017). Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer. BMC Cancer 17, 727. https://doi.org/10.1186/s12885-017-3726-2
- Ricardo, S., Vieira, A.F., Gerhard, R., Leitao, D., Pinto, R., Cameselle-Teijeiro, J.F., Milanezi, F., Schmitt, F., and Paredes, J. (2011). Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J. Clin. Pathol. 64, 937-946. https://doi.org/10.1136/jcp.2011.090456
- Rizeq, B., Zakaria, Z., and Ouhtit, A. (2018). Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression. Cancer Sci. 109, 33-42. https://doi.org/10.1111/cas.13437
- Rodini, C.O., Lopes, N.M., Lara, V.S., and Mackenzie, I.C. (2017). Oral cancer stem cells - properties and consequences. J. Appl. Oral Sci. 25, 708-715. https://doi.org/10.1590/1678-7757-2016-0665
- Santiago-Gomez, A., Kedward, T., Simoes, B.M., Dragoni, I., NicAmhlaoibh, R., Trivier, E., Sabin, V., Gee, J.M., Sims, A.H., Howell, S.J., et al. (2019). PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancer. Cancer Lett. 458, 66-75. https://doi.org/10.1016/j.canlet.2019.05.014
- Scadden, D.T. (2006). The stem-cell niche as an entity of action. Nature 441, 1075-1079. https://doi.org/10.1038/nature04957
- Scheel, C., Eaton, E.N., Li, S.H., Chaffer, C.L., Reinhardt, F., Kah, K.J., Bell, G., Guo, W., Rubin, J., Richardson, A.L., et al. (2011). Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145, 926-940. https://doi.org/10.1016/j.cell.2011.04.029
- Shi, X., Chen, G., Liu, X., Qiu, Y., Yang, S., Zhang, Y., Fang, X., Zhang, C., and Liu, X. (2015). Scutellarein inhibits cancer cell metastasis in vitro and attenuates the development of fibrosarcoma in vivo. Int. J. Mol. Med. 35, 31-38. https://doi.org/10.3892/ijmm.2014.1997
- Skvortsov, S., Debbage, P., and Skvortsova, I. (2014). Proteomics of cancer stem cells. Int. J. Radiat. Biol. 90, 653-658. https://doi.org/10.3109/09553002.2013.873559
- Song, M. and Giovannucci, E.L. (2015). Cancer risk: many factors contribute. Science 347, 728-729. https://doi.org/10.1126/science.aaa6094
- Vinogradov, S. and Wei, X. (2012). Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine (Lond.) 7, 597-615. https://doi.org/10.2217/nnm.12.22
- Wang, R., Lv, Q., Meng, W., Tan, Q., Zhang, S., Mo, X., and Yang, X. (2014). Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors. J. Thorac. Dis. 6, 829-837.
- Yan, Y., Zuo, X., and Wei, D. (2015). Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target. Stem Cells Transl. Med. 4, 1033-1043. https://doi.org/10.5966/sctm.2015-0048
- Yang, F., Xu, J., Tang, L., and Guan, X. (2017). Breast cancer stem cell: the roles and therapeutic implications. Cell. Mol. Life Sci. 74, 951-966. https://doi.org/10.1007/s00018-016-2334-7
- Zhong, G., Qin, S., Townsend, D., Schulte, B.A., Tew, K.D., and Wang, G.Y. (2019). Oxidative stress induces senescence in breast cancer stem cells. Biochem. Biophys. Res. Commun. 514, 1204-1209. https://doi.org/10.1016/j.bbrc.2019.05.098
- Zhu, P. and Fan, Z. (2018). Cancer stem cells and tumorigenesis. Biophys. Rep. 4, 178-188. https://doi.org/10.1007/s41048-018-0062-2
Cited by
- Polycystin-1 Enhances Stemmness Potential of Umbilical Cord Blood-Derived Mesenchymal Stem Cells vol.22, pp.9, 2020, https://doi.org/10.3390/ijms22094868